Research Area News

Instrumentation Research News

Side-port Endoscopic Imaging System with Macroscopic and Microscopic Field of View
Purdue-affiliated startup developing non-invasive, effective contact lenses and glasses to treat glaucoma, prevent blindness
Richard Borgens is featured in Purdue Today's "Inventors and Innovators" for developing the drug Ampyra, which has received approval from the U.S. Food and Drug Administration for improving motor function in patients with multiple sclerosis.
An old drug with new potential: WWII chemical-weapon antidote shows early promise as treatment for spinal cord injuries.
Brad Duerstock and colleagues have developed a device that enables people with visual impairments to interpret images from a microscope in real-time. The touch-feedback device, featured in New Scientist magazine, is a promising assistive technology for visually impaired students and scientists in STEM careers.
Bionode LLC, a Purdue-affiliated startup, is developing a treatment for glaucoma to prevent blindness.
Michael Ladisch co-authors Human pathogens in plant biofilms: Formation, physiology, and detection in Biotechnology and Bioengineering.
Chi Hwan Lee, an assistant professor of biomedical engineering and mechanical engineering, and Jacqueline Linnes, an assistant professor of biomedical engineering, both received the 2016 Purdue Research Foundation (PRF) International Travel Grants.
First author Heui Chang Lee publication, An efficient iterative CBCT reconstruction approach using gradient projection sparse reconstruction algorithm, was recently published by Oncotarget.
Researchers have developed a urine test revealing the presence of a neurotoxin that likely worsens the severity and pain of spinal cord injuries, suggesting a new personalized treatment the injuries.
Babak Ziaie, a professor of biomedical engineering and electrical and computer engineering, research team developed a palm-sized patch that changes color to indicate different level of hydration.
The $10 million grant from the National Institutes of Health’s Stimulating Peripheral Activity to Relieve Conditions (SPARC) program is target to better understand the stomach’s neural circuitry and whether bioelectronics medicine can aid conditions such as diabetes or obesity.
GlaxoSmithKline, a global health care company, provided Professor Pedro Irazoqui a $1 million award to pursue research into a device that would allow a patient to control bladder function using a phone.
The Institute of Electrical and Electronics Engineering (IEEE) recognized the work Pedro Irazoqui, a professor of biomedical engineering and electrical and computer engineering, and his research team has conducted on vagus nerve stimulation.